Absolute Clinical Research

Phoenix, Arizona 85323

0 studies enrolling now · 7 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Diseases, Chronic Kidney Disease, Chronic Kidney Disease (CKD), Colorectal Cancer, Covid19, Efficacy and Safety, Elevated Lp(a), Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes

Studies at this site

• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• Informed Choice - Compass — Stopped early
• A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin — Completed
• The Prevent Severe COVID-19 (PRESECO) Study — Completed
• Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness — Completed